Plant derived anticancer agents: A review.
Loading...
Date
2013-02
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Cancer is a major public health burden in both developed and developing countries. Plant-derived compounds have been an important source of several
clinically useful anti-cancer agents including taxol, vinblastine, vincristine, the camptothecin derivatives, topotecan and irinotecan, and etoposide derived from
epipodophyllotoxin are in clinical use all over the world. About 30 plant derived compounds have been isolated so far and are currently under clinical trials. Cancer
chemopreventive agents, many of which are natural products, are capable of preventing or inhibiting the process of carcinogenesis. As with other pharmaceutical
agents useful for disease prevention, a pharmacoeconomic analysis of a cancer chemopreventive formulation would need to be considered, and the composition of
the formulation should improve over time. A number of promising new agents are in clinical development based on selective activity against cancer-related
molecular targets, including flavopiridol, roscovitine, combretastatin A-4 phosphate , betulinic acid and silvestrol are in clinical or preclinical development.
Description
Keywords
Cancer, clinical trial, vinka alkaloid, epipodophyllotoxin, taxanes, camptothecine, cephalotaxanes, flavones, stilbenes
Citation
Sisodiya Preeti Singh. Plant derived anticancer agents: A review. International Journal of Research and Development in Pharmacy and Life Sciences. 2013 Feb-Mar; 2(2): 293-308.